Melanoma

Melanoma is a malignant tumour of melanocytes. Melanocytes predominantly occur in the skin but can be found elsewhere, especially the eye. The vast majority of melanomas originate in the skin.

Abraxis BioScience to Create Abraxis Health – Pioneering Personalized Medicine

Abraxis BioScience Announces Plan to Create Abraxis Health, a New Enterprise Focused on Biomarkers and Personalized Medicine – Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced that the Board of Directors has approved a strategic plan to create Abraxis Health, Inc., an independent, stand-alone company to be spun-off from Abraxis BioScience that will be dedicated to becoming a fully integrated, next-generation, evidence-based, personalized healthcare company.

Skin odor may diagnose skin cancer

Skin cancer could be diagnosed by the distinctive chemical odor it gives off, say US researchers. – Chemists described the first identification of a specific “odor profile” for skin cancer, a discovery that could form the basis of a rapid, non-invasive test for diagnosing the most common type of cancer in the United States.

Moisturisers may increase skin cancer risk

Moisturisers used by millions of people may be increasing the risk of common skin cancer like melanoma. – Moisturisers used by millions of people may be increasing the risk of common skin cancer like melanoma, hinted by researchers. However, the researchers had cautioned that the experiments were carried out on mice, but the majority of moisturisers have not gone through skin cancer safety checks.

New therapy promising for melanoma skin cancer

The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. – The combination of two different biotherapies (interferon alfa-2b and tremelimumab) may be beneficial for patients with inoperable melanoma, revealed by researchers in US.

New melanoma gene close to be identified

Results published today from a study led by researchers from The Translational Genomic Research Institute (TGen) in Phoenix, Arizona and The Queensland Institute of Medical Research (QIMR), Queensland, Australia, however, may yet change these statistics. The team is close to discovering a new gene that could help explain variation in melanoma risk. – The researchers are close to discovering a new gene that could help explain variation in melanoma risk. They have identified a region on chromosome 20 (20q11.22) that influences a person’s risk of developing melanoma.

International Cancer Genome Consortium sets sights on cancer

Researchers from four continents announced the launch of the International Cancer Genome Consortium (ICGC), a major collaboration designed to identify the key genetic mutations involved in up to 50 types of cancer. – The International Cancer Genome Consortium (ICGC), which includes the Wellcome Trust and the Wellcome Trust Sanger Institute in the UK, will generate a valuable resource enabling the development of new and better ways of diagnosing, treating and preventing cancer.

Melanoma skin cancer rising in Victoria

Number of Victorians affected by melanoma is at the highest level ever. Melanoma overtook lung cancer and is now the fourth most common cause of cancer in Victorians. – New figures from The Cancer Council Victoria show that the number of Victorians affected by melanoma is at the highest level ever. Latest figures from the Victorian Cancer Registry show that in 2005, melanoma overtook lung cancer and is now the fourth most common cause of cancer in Victorians.

Researchers identify protein that fuels ovarian cancer

Researchers identify protein that fuels ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle. – A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.

Uninsured diagnosed with an advanced stage cancer

Uninsured or Medicaid-insured patients are far more likely to be diagnosed with an advanced stage cancer than those with private insurance, according to a new American Cancer Society study of 3.5 million cancer patients with 12 of the most common cancer types. – A new American Cancer Society study of twelve types of cancer among more than 3.5 million cancer patients finds uninsured patients were significantly more likely to present with advanced stage cancer compared to patients with private insurance.

IGFBP7 protein may stop melanoma skin cancer

One might call it a tale of two melanocytes. Given the same genetic mutation, why does one melanocyte shut down growth and become a relatively benign mole, while another rages out of control and develops into deadly melanoma” – Howard Hughes Medical Institute (HHMI) researchers have uncovered a protein that stops the growth of melanoma, a cancer that develops from pigment-producing cells in the skin called melanocytes.

Health Newstrack